A Phase II Study of GW786034 in Patients With Non Small Cell Lung Cancer Who Have Failed at Least Two Prior Chemotherapy Regimens. An Institutional Pilot Study.
Phase of Trial: Phase II
Latest Information Update: 03 Jun 2014
At a glance
- Drugs Pazopanib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 20 Sep 2013 Status changed from suspended to recruiting as reported by ClinicalTrials.gov.
- 20 Sep 2013 Planned End Date changed from 1 Dec 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.
- 17 May 2013 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.